BioSpace News Archive

Halozyme Therapeutics, Inc. today announced that it intends to offer, subject to market conditions and other factors, $500 million aggregate principal amount of convertible senior notes due 2028 (the “Convertible Notes”).

Verogen, Inc. and Gene by Gene today announced a partnership to accelerate the adoption of forensic investigative genetic genealogy.

Monod Bio, a life sciences company developing custom diagnostic biosensors that emit light to detect specific biomolecules of interest, today announced it has raised a $25M seed financing round.

RenovoRx, Inc. today reported its financial results for the quarter ended June 30, 2022.

Black Bird Biotech, Inc. announced that the members of its Board of Directors have agreed to exchange a total of nearly 124 million shares, or approximately 36%, of the Company’s outstanding common stock for shares of a new Series A Preferred Stock.

Petros Pharmaceuticals, Inc. today announced financial results for the second quarter ended June 30, 2022.

Vaccinex, Inc. today announced financial results for the second quarter ended June 30, 2022 and provided a corporate update on key events since April, 2022 (the last 5 months).

HiFiBiO Therapeutics announced today a clinical trial supply agreement with Novartis to evaluate tislelizumab, an anti-PD-1 immune checkpoint inhibitor, in combination with HiFiBiO’s HFB200301, an investigational first-in-class monoclonal anti-TNFR2 agonist antibody for the potential treatment of advanced solid tumor indications.

Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the second quarter for the period ended June 30, 2022.

ContraFect Corporation announces the publication of a manuscript in the Journal of Bone and Joint Infection, a leading peer-reviewed journal dedicated to the study of osteo-articular and soft-tissue infections.